LEP

leptin

LEP; leptin; obesity factor; OB; obese; OBS;

LEPR

leptin receptor

OBR; OB-R; CD295; LEP-R; LEPR; leptin receptor;

LEPRE1

leucine proline-enriched proteoglycan (leprecan) 1

LEPRE1; leucine proline-enriched proteoglycan (leprecan) 1; prolyl 3-hydroxylase 1; GROS1; growth suppressor 1; LEPRECAN; MGC117314; P3H1; prolyl 3 hydroxylase 1; leucine- and proline-enriched proteoglycan 1; OI8;

LEPREL4

leprecan-like 4

NO55; SC65; NOL55; synaptonemal complex protein SC65; OTTHUMP00000164758; leprecan-like protein 4; nucleolar autoantigen No55; nucleolar autoantigen (55kD); nucleolar autoantigen, 55kDa; LEPREL4; leprecan-like 4;

EPM2A

epilepsy, progressive myoclonus type 2A, Lafora disease (laforin)

EPM2A; epilepsy, progressive myoclonus type 2A, Lafora disease (laforin); epilepsy, progressive myoclonus type 2, Lafora disease (laforin); laforin; LD; LDE; LAFPTPase; lafora PTPase; EPM2; MELF;

Leptin qA

Leptin Antagonist Quadruple Mutant

CLN8

ceroid-lipofuscinosis, neuronal 8 (epilepsy, progressive with mental retardation)

CLN8; ceroid-lipofuscinosis, neuronal 8 (epilepsy, progressive with mental retardation); C8orf61, chromosome 8 open reading frame 61 , EPMR; protein CLN8; FLJ39417; EPMR; C8orf61;

LEPREL2

leprecan-like 2

LEPREL2; leprecan-like 2; prolyl 3-hydroxylase 3; GRCB; HSU47926; P3H3; prolyl 3 hydroxylase 3; B protein; protein B; gene rich cluster, B; leprecan-like 2 protein; leprecan-like protein 2;

Leprotl1

leptin receptor overlapping transcript-like 1

LEPROTL1;leptin receptor overlapping transcript-like 1;ENSMUSG00000031513;AI854296;1110067H13Rik;1520402O14Rik;8 A4;8;leptin receptor overlapping transcript-like 1;leptin receptor overlapping transcript-like 1;

LEPREL1

leprecan-like 1

P3H2; Mlat4; AW553532; 4832416N06;

LEPROT

leptin receptor overlapping transcript

Obrgrp; Ob-Rgrp;

Laforin

epilepsy, progressive myoclonus type 2A, Lafora disease (laforin)

EPM2; MELF;